Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial.
Saved in:
| Title: | Factors Associated with Health Care Providers' Preference for Forgoing an Oral Lead-In Phase When Initiating Long-Acting Injectable Cabotegravir and Rilpivirine in the SOLAR Clinical Trial. |
|---|---|
| Authors: | Karver TS; Department of Prevention and Community Health, The George Washington University Milken Institute School of Public Health, Washington, District of Columbia, USA.; Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Pascual-Bernaldez M; ViiV Healthcare, Madrid, Spain., Berni A; GlaxoSmithKline, West Uxbridge, United Kingdom., Hnoosh A; Formerly with ViiV Healthcare, Brentford, United Kingdom., Castagna A; IRCCS San Raffaele Hospital, Milan, Italy., Messiaen P; Department of Infectious Diseases and Immunity, Jessa Hospital, Hasselt, Belgium.; Faculty of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium., Puerto MJG; Universitat de València, Valencia, Spain., Bloch M; Holdsworth House Medical Practice, and University of New South Wales, Sydney, Australia.; Department of Medicine, University of New South Wales, Sydney, Australia., Adachi E; Department of Infectious Diseases and Applied Immunology, Hospital of the Institute of Medical Science, University of Tokyo, Tokyo, Japan., Sinclair G; PrismHealth North Texas, Dallas, Texas, USA., Felizarta F; Private Practice, Bakersfield, California, USA., Angel JB; The Ottawa Hospital Research Institute, Ottawa, Canada., Sutton K; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Sutherland-Phillips D; ViiV Healthcare, Research Triangle Park, North Carolina, USA., D'Amico R; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Kerrigan D; Department of Prevention and Community Health, The George Washington University Milken Institute School of Public Health, Washington, District of Columbia, USA. |
| Source: | AIDS patient care and STDs [AIDS Patient Care STDS] 2023 Jan; Vol. 37 (1), pp. 53-59. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9607225 Publication Model: Print Cited Medium: Internet ISSN: 1557-7449 (Electronic) Linking ISSN: 10872914 NLM ISO Abbreviation: AIDS Patient Care STDS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
